Nang Kuang Pharmaceutical Co., Ltd. (1752.TW) TAI
Currency In TWD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.76B |
| Enterprise Value | 4.07B |
| P/E Ratio | 15.32 |
| PEG Ratio | -0.65 |
| Price/Sales Ratio | 1.49 |
| Price/Book Ratio | 1.29 |
| Enterprise/Revenue | 1.64 |
| Enterprise/EBITDA | 7.7 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.1 |
| Operating Margin | 0.12 |
AD
Management Effectiveness
| Return On Assets | 0.05 |
| Return On Equity | 0.08 |
Income Statement
| Revenue | 2.16B |
| Revenue/Share | 21.1 |
| Gross Profit | 768.86M |
| EBITDA | 478.81M |
| Net Income | 243.95M |
| Diluted EPS | 2.42 |
Balance Sheet
| Total Cash | 383.56M |
| Total Cash/Share | 3.84 |
| Total Debt | 684.64M |
| Total Debt/Equity | 0.28 |
| Current Ratio | 1.41 |
| Book Value Per Share | 24.13 |
Price History
| 52-Week Change | -20.56 |
| 52-Week High | 39.55 |
| 52-Week Low | 30.9 |
| Moving Average 50 Days | 31.65 |
| Moving Average 200 Days | 33.78 |
Statistics
| Average Volume | 59,353 |
| Shares Outstanding | 100.99M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 1.6 |
| Trailing Annual Dividend Yield | 5.14 |
| Payout Ratio | 0.4 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
